Evidence map›Paper›PMID 32972359›Full record

ArticleBMC public health2020

Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.

Myrtille Prouté, Sophie Le Coeur, Métrey H Tiv, Timothée Dub, Parinya Jongpaijitsakul, Anantika Ratnamhin, Chaisiri Angkurawaranon, Apinun Aramrattana, Marc Lallemant

Abstract read
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Myrtille ProutéFrench Institute for Demographic Studies (INED), Mortality, Health and Epidemiology unit, 9 cours des Humanités, CS 50004, 93322, Aubervilliers, France. myrtille.proute@gmail.com.ORCID http://orcid.org/0000-0003-1505-6392
Sophie Le CoeurFrench Institute for Demographic Studies (INED), Mortality, Health and Epidemiology unit, 9 cours des Humanités, CS 50004, 93322, Aubervilliers, France.
Métrey H TivFrench Institute for Demographic Studies (INED), Mortality, Health and Epidemiology unit, 9 cours des Humanités, CS 50004, 93322, Aubervilliers, France.
Timothée DubFrench Institute for Demographic Studies (INED), Mortality, Health and Epidemiology unit, 9 cours des Humanités, CS 50004, 93322, Aubervilliers, France.
Parinya JongpaijitsakulFrench National Research Institute for Sustainable Development (IRD), IRD174/PHPT, 195 Kaew Nawarat Road (3-4 Fl.) Wat Ked, Muang Chiang Mai, 50000, Thailand.
Anantika RatnamhinFrench National Research Institute for Sustainable Development (IRD), IRD174/PHPT, 195 Kaew Nawarat Road (3-4 Fl.) Wat Ked, Muang Chiang Mai, 50000, Thailand.
Chaisiri AngkurawaranonFaculty of Medicine, Department of Family Medicine, Chiang Mai University, Chiang Mai, Thailand.
Apinun AramrattanaFaculty of Medicine, Department of Family Medicine, Chiang Mai University, Chiang Mai, Thailand.
Marc LallemantFrench National Research Institute for Sustainable Development (IRD), IRD174/PHPT, 195 Kaew Nawarat Road (3-4 Fl.) Wat Ked, Muang Chiang Mai, 50000, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople who inject drugs (PWID) are the most exposed to hepatitis C virus (HCV). In Thailand, drug use is highly criminalized, and harm reduction services are scarce. This study estimates risky injection practices and assesses the proportion of HCV awareness and screening in the PWID population in Northern Thailand.

methodsWe used respondent-driven sampling (RDS) to recruit PWID in Chiang Mai Province. Social and behavioural data were collected through face-to-face interviews at an addiction treatment facility. Weighted population estimates were calculated to limit biases related to the non-random sampling method. Univariate and multivariate analyses were performed to study factors associated with HCV awareness and screening.

resultsOne hundred seventy-one PWID were recruited between April 2016 and January 2017. Median age was 33 (Interquartile range: 26-40) years, 12.2% were women, and 49.4% belonged to a minority ethnic group. Among participants, 76.8% injected heroin, 20.7% methadone, and 20.7% methamphetamine. We estimate that 22.1% [95% CI: 15.7-28.6] of the population had shared needles in the last 6 months and that 32.0% [95% CI: 23.6-40.4] had shared injection material. Only 26.6% [95% CI: 17.6-35.6] had heard of HCV. Factors independently associated with knowledge of HCV included belonging to a harm reduction organization (adjusted odds ratio (aOR) = 5.5 [95% CI: 2.0-15.3]) and voluntary participation in a drug rehabilitation programme (aOR = 4.3 [95% CI: 1.3-13.9]), while Lahu ethnicity was negatively associated (aOR = 0.3 [95% CI: 0.1-0.9]). We estimate that 5% of the PWID population were screened for HCV; the only factor independently associated with being screened was membership of a harm reduction organization (aOR = 5.7 [95% CI: 1.6-19.9]).

conclusionOur study reveals that the PWID population is poorly informed and rarely screened for HCV, despite widespread risky injection practices. A public health approach aimed at reducing the incidence of HCV should target the PWID population and combine harm reduction measures with information and destigmatization campaigns. Civil society organizations working with PWID are a major asset for the success of such an approach, based on their current positive interventions promoting awareness of and screening for HCV.

Indexed as

Hepatitis CHIV InfectionsPharmaceutical PreparationsSubstance Abuse, IntravenousAdultCross-Sectional StudiesFemaleHepacivirusHumansMalePrevalenceRisk-TakingSampling StudiesSurveys and QuestionnairesThailandPharmaceutical PreparationsHCVPeople who inject drugs PWIDRespondent-driven sampling RDSThailand

Identifiers

PMID32972359
PMCPMC7517806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.